CN101549766A - Tube vessel having a closure film and a tube filled with content in the vehicle - Google Patents
Tube vessel having a closure film and a tube filled with content in the vehicle Download PDFInfo
- Publication number
- CN101549766A CN101549766A CNA2009100078772A CN200910007877A CN101549766A CN 101549766 A CN101549766 A CN 101549766A CN A2009100078772 A CNA2009100078772 A CN A2009100078772A CN 200910007877 A CN200910007877 A CN 200910007877A CN 101549766 A CN101549766 A CN 101549766A
- Authority
- CN
- China
- Prior art keywords
- tubular container
- content
- closing membrane
- quality
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D35/00—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor
- B65D35/44—Closures
- B65D35/46—Closures with valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D35/00—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor
- B65D35/24—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor with auxiliary devices
- B65D35/28—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor with auxiliary devices for expelling contents
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Tubes (AREA)
- Closures For Containers (AREA)
- Packages (AREA)
Abstract
The invention provides a tube vessel having a closure film with small air flow-back and simple construction and a tube using the tube vessel. The tube vessel 1 having a closure film comprises an oral part 2 of the closure film 5 to be perforated by a needle 10 of a cover 9 and a tubular body part 8, characterized in that the body part 8 comprises an aluminum layer with wall thickness of below 50 Mum and the diameter of the needle 10 of the cover 9 and the diameter of the hole of the closure film 5 perforated by the needle 10 are below 2mm.
Description
Technical field
The present invention relates to a kind of tubular container, in more detail, relate to the tubular container of the band closing membrane that the air circulation (ェ ァ one バ ッ Network) that makes tubular container reduced and the pipe that in this container, is filled with content with closing membrane.
Background technology
Patent documentation 1: Japanese kokai publication hei 9-202338 number
In the past, as the general tubular container of filling contents such as medicament such as cream, ointment, the tubular container 50 that is made of synthetic resin or laminate was as shown in Figure 8 arranged.This tubular container 50 is after extruding content 51, and directly the restoring force by tubular container 50 makes air 52 flow into (air circulation) in tubular container 50, so the air 52 that existence refluxes mixes with content 51, the problem of content deterioration.
At this, there is the tubular container of band boiler check valve as shown in Figure 9.Symbol 100 expression vessels among the figure, chimeric on the oral area 101 of this vessel 100 have a boiler check valve 102.And, spheroid 106 being housed in the spheroid accommodation section 103 of this boiler check valve 102, spheroid 106 is at the ball stop part 109 on top and move between the jut 108 that forms on the bottom 104 easy on and off.Cover 107 by on the oral area 101 of this vessel 100, screwing togather, can be with the closure of openings of the oral area 101 of vessel 100.
These chimeric fill content in the tubular container 100,200 of boiler check valve after, if the body of extruded tubular container 100,200, then upwards push the ball body 106 or ligule spool 206 are discharged to the outside with content.When stopping body to tubular container 100,200 and pushing, when the restoring force of the body by tubular container 100,200 makes the content that remains in spheroid accommodation section 103 or the tube portion 203 get back in the tubular container 100,200, also may suck air outside, but, spheroid 106 or ligule spool 206 are by stopping up valve opening 105,205, can prevent that the content that upwards outpours by spheroid 106 or ligule spool 206 from carrying out adverse current in vessel 100,200, can prevent the air circulation in vessel 100,200 simultaneously.As the document of such boiler check valve 200, patent documentation 1 is arranged.
Summary of the invention
The problem that invention will solve
But, in the tubular container of in the past band closing membrane, have problem shown below.
(1) before the content in the customer uses tubular container, though content was placed in the mode of ingress of air not in sales stages such as circulation, displays, but after closing membrane is staved, breaks a seal, content extruded use after, because the easy elastic force of body ground recovers, the aperture that is formed by needle body is 2.0～8.0mm size in addition, therefore air circulation is in tubular container, easily and contents mixed.Therefore, content deterioration at short notice.
(2) though the tubular container that is provided with boiler check valve at oral area can suppress air circulation, the manufacturing cost height, the structure of oral area complicates simultaneously.
The present invention is conceived to such problem and the invention carried out, its purpose is, provide the tubular container of band closing membrane to reach the pipe that in this container, is filled with content, wherein, the tubular container of band closing membrane does not use boiler check valve, and the air that directly is back in the tubular container after extruding content significantly reduces, and is simple in structure, manufacturing cost is cheap, the keeping quality excellence of the content behind the Kaifeng.
Be used to solve the means of problem
In order to solve this problem, the solution of the invention of the 1st aspect of the present invention record is the tubular container of band closing membrane, it possesses: oral area and barrel-contoured body with closing membrane of the needle body perforation for the treatment of tegmentum, it is characterized in that, above-mentioned body has aluminium lamination, the wall thickness of this aluminium lamination is below the 50 μ m, and the diameter in the hole of the diameter of the needle body of above-mentioned lid and the closing membrane of being bored a hole by this needle body is below the 2mm.
The solution of the invention that the 2nd aspect is put down in writing is the tubular container of band closing membrane, it is characterized in that, replaces the aluminium lamination of the body of above-mentioned tubular body, is provided with the gas barrier resin layer.
The solution of the invention that the 3rd aspect is put down in writing is above-mentioned any tubular container of band closing membrane, it is characterized in that, diameter by above-mentioned closing membrane leak free discharge orifice is bigger than the hole of being bored a hole on closing membrane, form hydrops portion thus in discharge orifice, the diameter of this hydrops portion is that 2mm is above, length is more than the 4mm.
The solution of the invention of the 4th aspect is above-mentioned any tubular container of band closing membrane, it is characterized in that the viscosity that is filled in the content in the above-mentioned tubular container is 100～10000mPas.
The solution of the invention of the 5th aspect is a kind of pipe, it is characterized in that, is made of the tubular container of above-mentioned band closing membrane and the content that is filled in this tubular container.
The solution of the invention of the 6th aspect is a kind of pipe, and wherein the foregoing thing contains effective component.
The solution of the invention of the 7th aspect is a kind of pipe, and wherein, the effective component of foregoing thing is selected from more than one in antihistaminic, antiinflammatory, antipruritic, antifungal agent, keratolytic, convergence Derma-Guard, local anesthetic and the humectant.
According to the present invention, because the boring ratio that forms by needle body on closing membrane discharge is young a lot, therefore, after content was extruded, the content that remains in the discharge orifice was difficult to get back in the tubular container.Therefore can significantly reduce the amount of air that is back in the tubular container, have the effect of the keeping quality excellence of content.In addition, owing to also boiler check valve can not used, therefore, has effect simple in structure, that manufacturing cost is cheap.
Description of drawings
Fig. 1 is the front cross-sectional view of wanting portion of expression the 1st embodiment of the present invention.
Fig. 2 is the X portion amplification profile of presentation graphs 1.
Fig. 3 is the amplification profile of the body layer structure of expression the 2nd embodiment of the present invention.
Fig. 4 is the amplification profile of the body layer structure of expression the 3rd embodiment of the present invention.
Fig. 5 is the front cross-sectional view of wanting portion of expression the 4th embodiment of the present invention.
Fig. 6 is the front cross-sectional view of wanting portion of the 5th embodiment of the present invention.
Fig. 7 is the Y portion amplification profile of Fig. 6.
Fig. 8 represents the state of air circulation, the front elevation of expression tubular container in the past.
Fig. 9 is a section-drawing of representing the tubular container of band boiler check valve in the past.
Figure 10 is a section-drawing of representing the tubular container of band boiler check valve in the past.
Nomenclature
1 tubular container, 2 oral areas
3 mouthfuls of top 4 discharge orifices (hydrops portion)
5 closing membrane 5a holes
Shoulder 7 pipe shoulders in 6
8,18,28,38 bodies
9 lids, 10 needle bodies
11 aluminium laminations, 12 resin beds
15 contents
21 gas barrier resin layers (polyethylene terephthalate)
22 resin beds, 31 gas barrier resin layers (nylon)
32 resin beds, 38 bodies
39 thinner wall section, 40 heavy sections
The specific embodiment
Below, based on accompanying drawing embodiments of the present invention are described.Fig. 1 is the front cross-sectional view of wanting portion of expression the 1st embodiment of the present invention, Fig. 2 is the X portion amplification profile of presentation graphs 1, Fig. 3 is the amplification profile of the body layer structure of expression the 2nd embodiment of the present invention, Fig. 4 is the amplification profile of the body layer structure of expression the 3rd embodiment of the present invention, Fig. 5 is the front cross-sectional view of wanting portion of expression the 4th embodiment of the present invention, Fig. 6 is the front cross-sectional view of wanting portion of expression the 5th embodiment of the present invention, and Fig. 7 is the Y portion amplification profile of presentation graphs 6.
The tubular container pipe of content (or be filled with) of having represented the band closing membrane of the 1st embodiment of the present invention among Fig. 1.Symbol 1 among the figure is a tubular container.This tubular container 1 has oral area 2 cylindraceous in top ends.Be provided with mouthful top 3 on the top of this oral area 2, be formed with in the inside on this mouthful top 3 and have the discharge orifice 4 that is used to make the hydrops effect that content temporarily accumulates concurrently.The lower end of this discharge orifice 4 is closed film 5 and seals.Be provided with the shoulder (シ ョ Le ダ one) 6,7 of circular cone shape below above-mentioned oral area 2, body 8 cylindraceous extends from the lower ends downward of this shoulder 6,7.
Above-mentioned closing membrane 5 is made of resin of aluminium foil or gas barrier property etc., and it is in the closure of openings with the upper end of oral area 2, in the scope of oral area 2 and shoulder 6,7, on its surface or the laminated single or multiple lift resin bed in the back side.That is, in this scope, closing membrane 5 is in the state of being clamped by the interior shoulder 6 of inner face side and the pipe shoulder 7 of exterior side.The resin bed of pipe shoulder 7 above the covering closing membrane 5, constitutes a mouthful top 3.
As the content in the tubular container that is filled in above-mentioned band closing membrane, for example can enumerate: liquid preparation, ointment, cream, gel cream or gel etc.Liquid preparation, cream, gel cream and gel contain alcohol, gelating agent (ゲ Le drug), oil content, water and inhibiter etc. usually.
For alcohol, can enumerate: preferred lower alcohol, the more preferably alcohol of carbon number 1～3.As the alcohol of carbon number 1～3, for example can enumerate: methyl alcohol, ethanol, isopropyl alcohol, normal propyl alcohol etc.As gelating agent, for example can enumerate: the acrylic polymer of carboxy vinyl polymer etc., the cellulose family macromolecule of hydroxypropyl methylcellulose, ethyl cellulose etc., polyvinyl alcohol etc.Oil content for example can be enumerated: the hydro carbons of squalane, liquid paraffin etc., the ester class of isopropyl myristate, diisopropyl adipate and myristic acid octyl group dodecyl ester etc. etc.
As inhibiter, can enumerate: cationic surfactant, anionic surfactant, ampholytic surface active agent, nonionic surfactant are preferably nonionic surfactant.As the concrete example of nonionic surfactant, can enumerate: the polyol fatty acid ester or the polyol alkyl ether of propylene glycol mono fatty acid ester, ethylene glycol fatty acid ester, fatty acid monoglyceride, polyglyceryl fatty acid ester, sorbitan fatty acid esters, sucrose fatty ester, methyl glucosamine fatty acid ester, alkyl polyglucoside etc.; The polyoxyethylene ether of polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene phytosterol, polyoxyethylene phytostanol, polyoxyethylene cholesterol, polyoxyethylene cholestanol, polyoxyethylene polyoxy-propylene etc.; Polyoxyethylene mono fatty acid ester, carbowax di fatty acid ester, polyoxyethylene fatty acid glyceride, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene sorbitol fatty acid ester, Glucam E-10 fatty acid ester, Emulsifier EL-60 solidify the ether-ether of castor oil, polyoxyethylene vegetable oil, polyoxyethylene alkyl ether fatty acid ester, polyoxyethylene polyoxypropylene glycol etc. etc., special preferably glycerine fatty acid ester, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters.The HLB of nonionic surfactant is preferably 2～18, is preferably 3～17 especially.For example, the HLB of fatty acid glyceride is preferably 3～10, is preferably 4～8 especially.The HLB of sorbitan fatty acid esters is preferably 2～10, is preferably 3～6 especially.The HLB of polyoxyethylene sorbitan fatty acid esters is preferably 9～18, is preferably 14～17 especially.
The content of alcohol is generally 25～60 quality % with respect to total amount in the liquid preparation, is preferably 30～55 quality %.The content of gelating agent is generally 0～5 quality % with respect to total amount, more preferably 0.05～5 quality %.The content of oil content is generally 0～10 quality % with respect to total amount, more preferably 1～8 quality %.The content of inhibiter is generally 0～10 quality % with respect to total amount, more preferably 0～5 quality %.The content of water is generally 20～60 quality % with respect to total amount, more preferably 30～50 quality %.
The content of alcohol is generally 0～25 quality % with respect to total amount in the cream, is preferably 0～10 quality %.The content of gelating agent is generally 0～5 quality % with respect to total amount, more preferably 0.05～2 quality %.The content of oil content is generally 5～30 quality % with respect to total amount, more preferably 7～30 quality %.The content of inhibiter is generally 0.01～10 quality % with respect to total amount, more preferably 0.05～5 quality %.The content of water is generally 20～90 quality % with respect to total amount, more preferably 40～80 quality %.
The content of alcohol is generally 25～60 quality % with respect to total amount in the gel cream, is preferably 30～50 quality %, is preferably 30～40 quality % especially.The content of gelating agent is generally 0.01～5 quality % with respect to total amount, and more preferably 0.05～5 quality % is preferably 0.5～2.5 quality % especially.The content of oil content is generally 5～30 quality % with respect to total amount, and more preferably 7～30 quality % are preferably 7～20 quality % especially.The content of inhibiter is generally 0.01～10 quality % with respect to total amount, and more preferably 0.05～5 quality % is preferably 0.1～5 quality % especially.The content of water is generally 20～60 quality % with respect to total amount, and more preferably 30～50 quality % are preferably 40～50 quality % especially.
The content of alcohol is generally 25～60 quality % with respect to total amount in the gel, more preferably 30～50 quality %.The content of gelating agent is generally 0.01～5 quality % with respect to total amount, is preferably 0.05～5 quality %.The content of oil content is generally 0～10 quality % with respect to total amount, more preferably 1～8 quality %.The content of inhibiter is generally 0～10 quality % with respect to total amount, more preferably 0～5 quality %.The content of water is generally 20～60 quality % with respect to total amount, more preferably 30～50 quality %.
In the content in being filled into above-mentioned tubular container, can contain effective component, various any composition (for example, pH conditioning agent, preservative agent, stabilizer and wetting agent) as required.
As effective component; have no particular limits; for example can enumerate: antihistaminic, antiinflammatory, antipruritic, antifungal agent, keratolytic, convergence Derma-Guard, local anesthetic and humectant etc., these effective components can use separately, also can make up more than 2 kinds and use.
As antihistaminic, for example can enumerate: benadryl hydrochloride, bagodryl hydrochloride, lauryl sulfate benadryl hydrochloride, chlorphenamine maleate, Isothipendyl Hydrochloride etc.
As antiinflammatory, for example can enumerate: hydrocortisone acetate, the acetate propionate hydrocortisone, prednisolone, methylprednisolone, Methylprednisolone Acetate, the Prednival 21-Acetate ester, Difluprednate, the two fluocortolones of vaiproic acid, fluocinolone acetonide (Off Le ォ シ ノ ロ Application ァ セ ト ニ De), fludroxycortide (Off Le De キ シ コ Le チ De), fluocinonide (Off Le ォ シ ノ ニ De), Halcinonide, Amcinonide, the flumethasone pivalate, Triamcinolone acetonide, dexamethasone, dexamethasone acetate, the valeric acid dexamethasone, the propionic acid dexamethasone, BDP, beclomeasone propionate, clobetasone butyrate, clobetasol propionate, acetic acid diflorasone, butyric acid betamethasone dipropionate; bufexamac; Bendazac; the steroidal class antiinflammatory of Flufenamic acid butyl ester etc.; The non-steroidal anti-inflammatory agent of tenoxicam, Indomethacin, C14H10Cl2NNaO2, Flufenamic acid, bufexamac, Zaltoprofen, naproxen, brufen, Flurbiprofen, Ketotifen, flurbiprofen axetil, fenbufen, loxoprofen sodium, felbinac, mefenamic acid, piroxicam, Ampiroxicam etc.
As antipruritic, for example can enumerate: Crotamiton, gaultherolin etc.
As antifungal agent, for example can enumerate: miconazole nitrate, bifonazole, CCZ, clotrimazole, econazole nitrate, Isoconeazole Nitrate, Oxiconazole Nitrate, sulconazole nitrate, ketoconazole, SS 717, nystatin, Natamycin, siccanin, trichomycin, pecilocin, tolciclate, Tolnaftate, butenafine hydrochloride, Terbinafine, compound undecenoic acid, Ciclopirox Olamine, exalamide, Haloprogin, phenyl-iodide undecenoic acid etc.
As keratolytic, for example can enumerate: salicylic acid, urea etc.
As the convergence Derma-Guard, for example can enumerate: guaiazulene, PVP-I, hyparinoids from animal organs etc.
As local anesthetic, for example can enumerate: Aminobenzoate, Oxybuprocaine, quinocaine, tetracaine hydrochloride, hydrochloric acid are to butyl amino benzoic Acid lignocaine ethyl ester (p-butylaminobenzoyldiethylaminoethyl hydrochloride), bupivacaine HCl, procaine hydrochloride, Mepivacaine HCL, Ropivacaine HCL hydrate, oxetacaine, piperidyl acetyl-amino ethyl benzoate, lidocaine, lidocaine hydrochloride etc.
As humectant, for example can enumerate: urea, hyparinoids from animal organs, 2-pyrrolidone-5-carboxylic acid, collagen, gamma oryzanol, gamma-Linolenic acid, linoleic acid, vitamin E, vitamin D, vitamin A, squalene, squalane, glycerine, carbowax, cholesterol, triglyceride, ceramide etc.
As the pH conditioning agent, can enumerate: the organic acid of citric acid, phosphoric acid, tartaric acid, lactic acid etc., the inorganic acid of hydrochloric acid etc., the alkali hydroxide metal of sodium hydroxide etc., the amine of triethanolamine, diethanolamine (DEA), diisopropanolamine etc.
As preservative agent, can enumerate: parabens, benzalkonium chloride etc.
As stabilizer, can enumerate: dibutyl hydroxy toluene, butylated hydroxyanisole (BHA), edetate etc.
In addition, as wetting agent, can enumerate: glycerine, ethylene glycol, propylene glycol, oleyl alcohol, 1, the polyalcohol of 3-butylene glycols, Isopropanediol, carbowax etc.
Need to prove that the content that is filled in the above-mentioned tubular container of liquid preparation, ointment, cream, cream-gel agent, gel etc. can be made according to known method (for example, the 15 correcting Pharmacopeia of Japan preparation general provisions etc.).
The body 8 of the tubular container 1 of the 1st embodiment of Fig. 1 is by making with reel reel (former anti-), welding of the mode of circle on the bottom of pipe shoulder 7.Constituting the reel of body 8, as shown in Figure 2, is to have the interlayer (gas barrier layer) that is made of aluminium foil 11 in inside, clamp the two sides and the laminated reel that constitutes by resin bed 12.As the resin bed 12 of the both sides of aluminium foil 11, be suitable for for example by the poly-vinyl resin that is selected from ldpe resin, straight chain shape ldpe resin, high-density polyethylene resin etc.; The ethylene methacrylic acid copolymer resin; The resin bed 12 of the multilayer that the resin in composite nylon resin or the pet resin etc. constitutes also can be the individual layer of poly-vinyl resin.
The wall thickness (size t shown in Figure 2) of the aluminium foil 11 by making this body 8 be 50 μ m following, be preferably 10～35 μ m, can make body 8 deliquescing, the restoring force of body 8 is reduced, can reduce air circulation thus.Need to prove that during less than 10 μ m, intensity is insufficient.In addition meanwhile, as shown in Figure 5, if (size a) is set in that 2mm is following, preferred 0.8～1.5mm will to cover the diameter of hole 5a of closing membrane 5 of the diameter of 9 needle body 10 and perforation, then after just content being extruded, air is difficult to enter in the tubular container 1, therefore, can reduce air circulation.If be set in below the 1.5mm, then air more is difficult to enter in the tubular container.During deficiency 0.8mm, be difficult to content is extruded.In addition, the difference of the diameter in the hole of the internal diameter of preferred discharge orifice 4 and closing membrane 5 is about 0.3～8.0mm.In the 1st embodiment of Fig. 1, the top of needle body 10 is coniform, and near the diameter the top is littler than the diameter of base portion.
In the past, after the content of tubular container 1 is extruded, air flow in the tubular container 1 immediately in large quantities, but, by setting the wall thickness of the aluminium foil 11 of body 8 thinner, and (size a) is set lessly, as a whole, the air circulation amount of pushing after (extruding) is reduced with the diameter of the hole 5a that is bored a hole of closing membrane 5.
Fig. 3 is the figure of expression the 2nd embodiment of the present invention, in this embodiment, replaces the aluminium lamination of body in the 1st embodiment, adopts pet resin layer 21 as the gas barrier resin layer as interlayer (gas barrier layer).Need to prove,, can also use polyvinylidene chloride resin, polyvinyl alcohol resin, ethylene-vinyl alcohol copolymer resins as the gas barrier resin layer.In addition, constitute for the layer of the resin bed 22 of the both sides of pet resin layer 21, identical with the 1st embodiment.In the present embodiment, the wall thickness and the 1st embodiment of the polyethylene terephthalate layer 21 of body 18 are set in below the 50 μ m in the same manner, are preferably 9～12 μ m, simultaneously, the diameter of the hole 5a of closing membrane 5 is set in below the 2mm, is preferably 0.8～1.5mm, reduce the restoring force of body 18 thus, can reduce simultaneously the amount that flow into the air in the tubular container 1, the air circulation amount after content just extruded is significantly reduced.
Fig. 4 is the figure of expression the 3rd embodiment of the present invention, replaces the aluminium lamination of body in the 1st embodiment, adopts the polyamide resin layer 31 as the gas barrier resin layer.Layer for the resin bed 32 of the both sides of polyamide resin layer 31 constitutes, and is identical with the 1st embodiment.In the present embodiment, identical with the 2nd embodiment, the wall thickness of the polyamide resin layer 31 of body 28 is set in below the 50 μ m, is preferably 10～25 μ m, simultaneously with the diameter of the hole 5a of closing membrane 5 (size a) be set in 2mm following, be preferably 0.8～1.5mm, reduce the restoring force of body 28 thus, can reduce simultaneously the amount that flow into the air in the tubular container 1, the air circulation amount after content just can having been extruded significantly reduces.
Fig. 5 is the figure of expression the 4th embodiment of the present invention, internal diameter (size b) by the discharge orifice 4 on the mouth top 3 that is formed at closing membrane 5 that makes tubular container 1 is bigger than the diameter of the hole 5a of the closing membrane 5 of boring a hole by needle body, and discharge orifice 4 is played a role as hydrops portion.The internal diameter of discharge orifice is set in more than the 2mm, preferably sets at 2～3mm; Length C is set in more than the 4mm, preferably sets at 4～10mm.Be set in 100～10000mPas (Brookfield viscometer, rotor No.4, revolution 60rpm, 25 ℃) by the viscosity that will be filled in the content in the tubular container 1 in addition, the air circulation after content just extruded is significantly reduced.And, under the following situation, promptly (1) aluminium lamination of body or the wall thickness of gas barrier resin layer are set in below the 50 μ m; (2) diameter in hole with the closing membrane of perforation is set in below the 2mm; (3) diameter (size b) of the hydrops portion on mouthful top is formed more than the 2mm, and to make the size C of hydrops portion 4 be more than the 4mm; (4) viscosity that will be filled in the content in the tubular container 1 is set in 100～10000mPas, and content accumulates in hydrops portion 4 in time for a long time, and content is not directly got back in the tubular container 1.Therefore, can prevent more significantly that air directly is back in the tubular container 1.That is, the invention that the of the present invention the 1st～3 embodiment 3 and present embodiment made up can prevent air circulation most effectively.
Fig. 6 is the figure of expression the 5th embodiment, near under the pipe shoulder 37, that is, forms the thinner wall section 39 of wall thickness at the upper end position of body 38, thereunder forms heavy section 40.As shown in Figure 7, thinner wall section 39 can be provided with ladder (size S) and form on any of periphery wall or internal perisporium.According to the 5th embodiment, can easily near body 38 under the pipe shoulder 37 be folded in the pipe shoulder 37, near the contents body 38 and the pipe shoulder 37 fully can be extruded.Even in this embodiment 5, under situation, also can prevent air circulation effectively with above-mentioned the 1st embodiment to the 4 embodiments combination.
Utilizability on the industry
The present invention before Kaifeng, can fully prevent not only that by closing membrane air is from the outside Enter, even and after just breaking a seal, also can prevent air return, therefore not only circulation, Even also can effectively prevent in the sales process and after use because air return causes The deterioration of content. Therefore, the tubular container that the present invention relates to be suitable for widely filling medicine, Food etc. can utilize widely.
Claims (7)
1, a kind of tubular container with closing membrane, it possesses: has the oral area and the barrel-contoured body of the closing membrane of the needle body perforation for the treatment of tegmentum, it is characterized in that,
Above-mentioned body has aluminium lamination, and the wall thickness of this aluminium lamination is below the 50 μ m, and the diameter in the hole of the diameter of the needle body of above-mentioned lid and the closing membrane of being bored a hole by this needle body is below the 2mm.
2, according to the tubular container of the above-mentioned band closing membrane of claim 1, it is characterized in that, replace the aluminium lamination of above-mentioned body, be provided with the gas barrier resin layer.
3, the tubular container of band closing membrane according to claim 1 and 2, it is characterized in that, diameter by above-mentioned closing membrane leak free discharge orifice is bigger than the hole of being bored a hole on closing membrane, forms hydrops portion thus in discharge orifice, and the diameter of this hydrops portion is that 2mm is above, length is more than the 4mm.
According to the tubular container of each described band closing membrane in the claim 1～3, it is characterized in that 4, the viscosity that is filled in the content in the above-mentioned tubular container is 100～10000mPas.
5, a kind of pipe, it is made of the tubular container of claim 1,2,3 or 4 band closing membrane and the content that is filled in this tubular container.
6, pipe according to claim 5 is characterized in that, the foregoing thing is the content that contains effective component.
7, pipe according to claim 6 is characterized in that, the effective component of foregoing thing is selected from more than one in antihistaminic, antiinflammatory, antipruritic, antifungal agent, keratolytic, convergence Derma-Guard, local anesthetic and the humectant.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008040538A JP5525135B2 (en) | 2008-02-21 | 2008-02-21 | Tube container with closure membrane and tube filled with contents |
| JP2008-040538 | 2008-02-21 | ||
| JP2008040538 | 2008-02-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101549766A true CN101549766A (en) | 2009-10-07 |
| CN101549766B CN101549766B (en) | 2012-09-26 |
Family
ID=41140649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100078772A Expired - Fee Related CN101549766B (en) | 2008-02-21 | 2009-02-20 | Tube vessel having a closure film and a tube filled with content in the vehicle |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP5525135B2 (en) |
| KR (1) | KR101589081B1 (en) |
| CN (1) | CN101549766B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102582924A (en) * | 2012-02-17 | 2012-07-18 | 上海万汇塑料包装容器有限公司 | Novel hose pipe and production technology thereof |
| CN107406168A (en) * | 2015-04-08 | 2017-11-28 | 藤森工业株式会社 | Tubular container |
| CN107912809A (en) * | 2016-10-10 | 2018-04-17 | 湖南中烟工业有限责任公司 | A kind of tobacco juice for electronic smoke capsule |
| CN109071059A (en) * | 2016-04-15 | 2018-12-21 | 京洛株式会社 | Peel container is laminated |
| CN110371464A (en) * | 2018-04-12 | 2019-10-25 | 创新产品品牌公司 | Cap is locked with improved locking cap insert to reduce the protection of the child for laminated tube that substance leaks after locking cap closure |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009285423A (en) * | 2008-06-02 | 2009-12-10 | Kowa Co | Drug preparation for external use |
| KR200487565Y1 (en) * | 2017-01-11 | 2018-10-05 | 권민재 | Disposable mist device |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3241977C2 (en) * | 1982-11-12 | 1985-11-28 | Automation Industrielle S.A., Vouvry | Packing room |
| JPH0624352Y2 (en) * | 1984-11-09 | 1994-06-29 | 大成化工株式会社 | Extruded tube with blind lid |
| JPS6451057U (en) * | 1987-09-19 | 1989-03-29 | ||
| JP3275150B2 (en) * | 1991-11-18 | 2002-04-15 | 大和製罐株式会社 | Shoulder and neck covering parts of tube container and method of manufacturing the same |
| JP2627386B2 (en) * | 1992-09-24 | 1997-07-02 | 田岡化学工業株式会社 | Cap with opening needle pin for instant adhesive |
| CN1281461C (en) * | 1999-05-31 | 2006-10-25 | 株式会社吉野工业所 | Tubular container made of synthetic resin |
| JP2003190254A (en) * | 2001-12-25 | 2003-07-08 | Takeuchi Press Ind Co Ltd | Closing film tube threadedly engaged with cap with needle |
| CN2516478Y (en) * | 2002-01-25 | 2002-10-16 | 王奎义 | Pressure direct-flow flexible container |
| JP4955282B2 (en) * | 2006-02-21 | 2012-06-20 | 武内プレス工業株式会社 | Manufacturing method of closed membrane tube container |
-
2008
- 2008-02-21 JP JP2008040538A patent/JP5525135B2/en active Active
-
2009
- 2009-02-03 KR KR1020090008251A patent/KR101589081B1/en active IP Right Grant
- 2009-02-20 CN CN2009100078772A patent/CN101549766B/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102582924A (en) * | 2012-02-17 | 2012-07-18 | 上海万汇塑料包装容器有限公司 | Novel hose pipe and production technology thereof |
| CN107406168A (en) * | 2015-04-08 | 2017-11-28 | 藤森工业株式会社 | Tubular container |
| CN109071059A (en) * | 2016-04-15 | 2018-12-21 | 京洛株式会社 | Peel container is laminated |
| CN107912809A (en) * | 2016-10-10 | 2018-04-17 | 湖南中烟工业有限责任公司 | A kind of tobacco juice for electronic smoke capsule |
| CN110371464A (en) * | 2018-04-12 | 2019-10-25 | 创新产品品牌公司 | Cap is locked with improved locking cap insert to reduce the protection of the child for laminated tube that substance leaks after locking cap closure |
| CN110371464B (en) * | 2018-04-12 | 2022-03-25 | 创新产品品牌公司 | Child-resistant locking cap for laminated tubes with improved locking cap insert to reduce leakage of substance after locking cap closure |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101549766B (en) | 2012-09-26 |
| JP2009196671A (en) | 2009-09-03 |
| KR20090091009A (en) | 2009-08-26 |
| KR101589081B1 (en) | 2016-01-27 |
| JP5525135B2 (en) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101549766B (en) | Tube vessel having a closure film and a tube filled with content in the vehicle | |
| AU2014309079B2 (en) | Film for flexible packaging for use in bag in box packaging and bags made therefrom | |
| US6609636B1 (en) | Flexible container for bag-in-box packaging system | |
| US20090283541A1 (en) | System and apparatus for dispensing pumpable products | |
| US8206034B2 (en) | Opening mechanism for a flexible container | |
| EP3854705A2 (en) | Package | |
| CA2407904A1 (en) | Stand-up bag of a heat-sealable plastic film for flowable products | |
| US20070246391A1 (en) | Retail package for flowable products | |
| MX2011006198A (en) | Dispensing system for dispensing a pumpable product. | |
| EP3287387A1 (en) | Structure having liquid membrane, and manufacturing method of said structure | |
| AU2016345371B2 (en) | Pouch type package and associated method for adapatation of such a package | |
| EP0729898A2 (en) | Film and pouch with patch of high elongation | |
| JP6877362B2 (en) | Systems and methods for in-line molding, filling, and sealing to form product packaging | |
| JP2009285423A (en) | Drug preparation for external use | |
| JP2017013369A (en) | Structure having lubricating layer | |
| EP3339208A1 (en) | Structure having liquid film and method for producing same | |
| EP3318137B1 (en) | Structure with liquid film formed on surface | |
| JP2000168770A (en) | Filling and packaging method for liquid food, and packaging material for paper container | |
| US20080245817A1 (en) | Flexible bag having a dispenser assembly | |
| JP2008307502A (en) | Fluid supplying apparatus | |
| JP2008105736A (en) | Pouch with mouth stopper | |
| JP2002264934A (en) | Laminated packaging material for paper container | |
| WO2017058138A1 (en) | Pouch with flexible self-sealing dispensing valve | |
| JP2003054589A (en) | Multi-layered squeezing tube container | |
| JP2006232300A (en) | Pouch with plug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120926 Termination date: 20170220 |